Showing results (361-370 of 431) with videos related to
Sort By:
Pageof 44
Breast Cancer Research and Treatment|August 16, 2024
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery systemJenna Bhimani, Kelli O'Connell, Sonia Persaud, et al.JCO Oncology Practice|December 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast CancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.JCO Clinical Cancer Informatics|February 14, 2025
Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing StudyPeng Wang, Kelli O'Connell, Jenna Bhimani, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2024
Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast CancerJenna Bhimani, Kelli O'Connell, Sonia Persaud, et al.JAMA Oncology|January 10, 2020
Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast CancerWendy A Woodward, William E Barlow, Reshma Jagsi, et al.Journal of the National Cancer Institute|October 1, 2011
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working groupMitch Dowsett, Torsten O Nielsen, Roger A'Hern, et al.Breast Cancer Research and Treatment|November 2, 2011
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancerAditya Bardia, Erin T Arieas, Zhe Zhang, et al.Breast Cancer Research and Treatment|March 24, 2010
Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancerSong Yao, William E Barlow, Kathy S Albain, et al.NPJ Breast Cancer|June 12, 2021
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patientsCostanza Paoletti, Meredith M Regan, Samuel M Niman, et al.Journal of the National Cancer Institute|November 9, 2013
An international Ki67 reproducibility studyMei-Yin C Polley, Samuel C Y Leung, Lisa M McShane, et al.Pageof 44